Marc Gottlieb, MD
Pulmonary Disease · Mobile, ALNPI 1306898325
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 280 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,552 and has fallen 89.3% since, to $166 in 2025.
Across 280 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$783
- AstraZeneca$634
- Boehringer Ingelheim$582
- Actelion Pharmaceuticals US, Inc.$505
- Grifols USA, LLC$297
- Electromed, Inc.$226
- plus $1K from 28 others
What the payments were for
- Food & beverage$4,450100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 65 | $783 |
| AstraZeneca | 34 | $634 |
| Boehringer Ingelheim | 32 | $582 |
| Actelion Pharmaceuticals US, Inc. | 28 | $505 |
| Grifols USA, LLC | 16 | $297 |
| Electromed, Inc. | 21 | $226 |
| Philips North America LLC | 9 | $136 |
| Mallinckrodt Enterprises LLC | 6 | $131 |
| Sanofi | 6 | $112 |
| Mylan Specialty L.p. | 6 | $107 |
| Angiodynamics, Inc. | 1 | $103 |
| Sunovion Pharmaceuticals Inc. | 8 | $89 |
| Johnson & Johnson | 10 | $87 |
| Jazz Pharmaceuticals Inc. | 4 | $78 |
| Harmony Biosciences LLC | 4 | $77 |
| Merck | 3 | $58 |
| Genentech USA, Inc. | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 3 | $52 |
| Mallinckrodt Hospital Products Inc. | 2 | $46 |
| Gilead | 2 | $39 |
| United Therapeutics Corporation | 3 | $35 |
| Circassia Inc. | 2 | $25 |
| Viatris Specialty LLC | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Vifor Pharma, Inc. | 1 | $19 |
| Insmed, Inc. | 1 | $18 |
| Novartis | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Pfizer | 1 | $17 |
| Olympus America Inc. | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Inogen, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$125
- OFEV$121
- Auryon Laser System 100-120 Vac$103
How this compares
$4,462 in reported general payments places this provider in the 55th percentile of 215 pulmonary disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Mobile
- Adrian DivittorioMobile$100K
- Peter LutzMobile$63K
- Virginia RadcliffMobile$23K
- Johnson HaynesMobile$21K
- Cynthia CrowderMobile$20K
- Philip AlmaloufMobile$14K
- Campbell SindelMobile$14K
- Chibuzo OdigweMobile$14K
- Caesar AgaganMobile$11K
- James DeanMobile$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.